<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02637427</url>
  </required_header>
  <id_info>
    <org_study_id>Pro20150001801</org_study_id>
    <secondary_id>1R34HL125804-01A1</secondary_id>
    <nct_id>NCT02637427</nct_id>
  </id_info>
  <brief_title>Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures</brief_title>
  <official_title>Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate prophylactic fresh frozen plasma transfusion in&#xD;
      patients with moderately elevated international normalized ratios (INR) prior to undergoing&#xD;
      an invasive procedure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fresh frozen plasma is used very frequently in the US. Many plasma transfusions are given&#xD;
      prior to a procedure in order to correct perceived bleeding risk, yet there is little&#xD;
      evidence to support that use of plasma reduces bleeding. There has never been an adequately&#xD;
      powered trial to establish the efficacy of plasma and document the risks. This pilot study&#xD;
      will evaluate the feasibility of conducting a research protocol that will lead to a large&#xD;
      scale clinical trial designed to evaluate the treatment effectiveness of prophylactic plasma&#xD;
      transfusion in patients with moderately elevated INRs prior to undergoing an invasive&#xD;
      procedure outside of the operating room.&#xD;
&#xD;
      Study subjects will be randomly allocated to either receive either plasma transfusion prior&#xD;
      to the procedure, or to no treatment. Study outcomes will be compared between the two study&#xD;
      arms. Recruitment rates, protocol adherence, and rates of study outcomes will be assessed to&#xD;
      determine the feasibility of the large scale trial.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 26, 2016</start_date>
  <completion_date type="Actual">November 2020</completion_date>
  <primary_completion_date type="Actual">June 28, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Hemoglobin Level</measure>
    <time_frame>within 2 days post procedure</time_frame>
    <description>Change from pre-procedure hemoglobin to lowest within 2 days after procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Red Blood Cell Transfusions</measure>
    <time_frame>within 2 days post procedure</time_frame>
    <description>Differences in number of units of red blood cell transfusions between the two study arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Transfusion Associated Cardiac Overload (TACO)</measure>
    <time_frame>within 2 days post procedure</time_frame>
    <description>Difference in rates between the two study arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Transfusion Related Acute Lung Injury (TRALI).</measure>
    <time_frame>with 2 days post procedure</time_frame>
    <description>Difference in rates between the two study arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Major Bleed</measure>
    <time_frame>with 2 days post procedure</time_frame>
    <description>2g/dL or greater fall in hemoglobin level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in International Normalized Ratio (INR) Level Post Procedure</measure>
    <time_frame>day of procedure</time_frame>
    <description>Change from pre-procedure INR level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in INR Level Day 1</measure>
    <time_frame>day 1 post procedure</time_frame>
    <description>Change from pre-procedure INR level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in INR Level Day 2</measure>
    <time_frame>day 2 post procedure</time_frame>
    <description>Change from pre-procedure INR level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality (Number of Participants)</measure>
    <time_frame>in-hospital up to 7 days</time_frame>
    <description>Death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Infection</measure>
    <time_frame>within 2 days post procedure</time_frame>
    <description>Pneumonia or blood stream infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With ICU Admission</measure>
    <time_frame>within 2 days post procedure</time_frame>
    <description>new admission to the intensive care unit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Blood Coagulation Disorders</condition>
  <condition>Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Fresh frozen plasma transfusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No transfusion</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No transfusions prior to the procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Fresh frozen plasma transfusion</intervention_name>
    <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
    <arm_group_label>Fresh frozen plasma transfusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. INR level between 1.50 and 2.50 inclusive&#xD;
&#xD;
          2. undergoing an invasive procedure at the bedside, endoscopy laboratory, or in radiology&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. undergoing a surgical procedure in the operating room;&#xD;
&#xD;
          2. active bleeding;&#xD;
&#xD;
          3. undergoing a procedure involving or proximal to the central nervous system or spinal&#xD;
             cord;&#xD;
&#xD;
          4. cardiac catheterization,&#xD;
&#xD;
          5. using 4 factor plasma concentrates&#xD;
&#xD;
          6. using systemic heparin/heparinoid therapy, direct factor X inhibitors and other&#xD;
             anticoagulants for which plasma will not correct prolonged INR;&#xD;
&#xD;
          7. platelet count less than 50,000/ul,&#xD;
&#xD;
          8. congenital coagulation disorders;&#xD;
&#xD;
          9. acquired disorders (i.e., lupus anticoagulant) for which plasma will not correct the&#xD;
             disorder;&#xD;
&#xD;
         10. women who are pregnant and;&#xD;
&#xD;
         11. unwillingness to consider blood transfusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey L Carson, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Rutgers Robert Wood Johnson Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins University, The Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Robert Wood Johnson University Hospital</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 16, 2015</study_first_submitted>
  <study_first_submitted_qc>December 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2015</study_first_posted>
  <results_first_submitted>July 2, 2021</results_first_submitted>
  <results_first_submitted_qc>July 23, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 17, 2021</results_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rutgers, The State University of New Jersey</investigator_affiliation>
    <investigator_full_name>Jeffrey L Carson, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Fresh frozen plasma</keyword>
  <keyword>Bleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 19, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/27/NCT02637427/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 19, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/27/NCT02637427/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Fresh Frozen Plasma Transfusion</title>
          <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
        </group>
        <group group_id="P2">
          <title>No Transfusion</title>
          <description>No transfusions prior to the procedure</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Fresh Frozen Plasma Transfusion</title>
          <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
        </group>
        <group group_id="B2">
          <title>No Transfusion</title>
          <description>No transfusions prior to the procedure</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="57"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.5" spread="18.0"/>
                    <measurement group_id="B2" value="58.2" spread="13.9"/>
                    <measurement group_id="B3" value="56.0" spread="16.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Liver disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Coronary artery disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Congestive heart failure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic Obstructive Pulmonary Disease (COPD)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Thromboembolism</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior history of bleeding</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Metastatic carcinoma</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Hemoglobin Level</title>
        <description>Change from pre-procedure hemoglobin to lowest within 2 days after procedure</description>
        <time_frame>within 2 days post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fresh Frozen Plasma Transfusion</title>
            <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
          </group>
          <group group_id="O2">
            <title>No Transfusion</title>
            <description>No transfusions prior to the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hemoglobin Level</title>
          <description>Change from pre-procedure hemoglobin to lowest within 2 days after procedure</description>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="1.0"/>
                    <measurement group_id="O2" value="-0.4" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Red Blood Cell Transfusions</title>
        <description>Differences in number of units of red blood cell transfusions between the two study arms</description>
        <time_frame>within 2 days post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fresh Frozen Plasma Transfusion</title>
            <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
          </group>
          <group group_id="O2">
            <title>No Transfusion</title>
            <description>No transfusions prior to the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Red Blood Cell Transfusions</title>
          <description>Differences in number of units of red blood cell transfusions between the two study arms</description>
          <units>units</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Transfusion Associated Cardiac Overload (TACO)</title>
        <description>Difference in rates between the two study arms</description>
        <time_frame>within 2 days post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fresh Frozen Plasma Transfusion</title>
            <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
          </group>
          <group group_id="O2">
            <title>No Transfusion</title>
            <description>No transfusions prior to the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Transfusion Associated Cardiac Overload (TACO)</title>
          <description>Difference in rates between the two study arms</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Transfusion Related Acute Lung Injury (TRALI).</title>
        <description>Difference in rates between the two study arms</description>
        <time_frame>with 2 days post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fresh Frozen Plasma Transfusion</title>
            <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
          </group>
          <group group_id="O2">
            <title>No Transfusion</title>
            <description>No transfusions prior to the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Transfusion Related Acute Lung Injury (TRALI).</title>
          <description>Difference in rates between the two study arms</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Major Bleed</title>
        <description>2g/dL or greater fall in hemoglobin level</description>
        <time_frame>with 2 days post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fresh Frozen Plasma Transfusion</title>
            <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
          </group>
          <group group_id="O2">
            <title>No Transfusion</title>
            <description>No transfusions prior to the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Major Bleed</title>
          <description>2g/dL or greater fall in hemoglobin level</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in International Normalized Ratio (INR) Level Post Procedure</title>
        <description>Change from pre-procedure INR level</description>
        <time_frame>day of procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fresh Frozen Plasma Transfusion</title>
            <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
          </group>
          <group group_id="O2">
            <title>No Transfusion</title>
            <description>No transfusions prior to the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Change in International Normalized Ratio (INR) Level Post Procedure</title>
          <description>Change from pre-procedure INR level</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.24" spread="0.26"/>
                    <measurement group_id="O2" value="0" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in INR Level Day 1</title>
        <description>Change from pre-procedure INR level</description>
        <time_frame>day 1 post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fresh Frozen Plasma Transfusion</title>
            <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
          </group>
          <group group_id="O2">
            <title>No Transfusion</title>
            <description>No transfusions prior to the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Change in INR Level Day 1</title>
          <description>Change from pre-procedure INR level</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.22" spread="0.19"/>
                    <measurement group_id="O2" value="-0.03" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in INR Level Day 2</title>
        <description>Change from pre-procedure INR level</description>
        <time_frame>day 2 post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fresh Frozen Plasma Transfusion</title>
            <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
          </group>
          <group group_id="O2">
            <title>No Transfusion</title>
            <description>No transfusions prior to the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Change in INR Level Day 2</title>
          <description>Change from pre-procedure INR level</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="0.39"/>
                    <measurement group_id="O2" value="0" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mortality (Number of Participants)</title>
        <description>Death</description>
        <time_frame>in-hospital up to 7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fresh Frozen Plasma Transfusion</title>
            <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
          </group>
          <group group_id="O2">
            <title>No Transfusion</title>
            <description>No transfusions prior to the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality (Number of Participants)</title>
          <description>Death</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Infection</title>
        <description>Pneumonia or blood stream infection</description>
        <time_frame>within 2 days post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fresh Frozen Plasma Transfusion</title>
            <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
          </group>
          <group group_id="O2">
            <title>No Transfusion</title>
            <description>No transfusions prior to the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Infection</title>
          <description>Pneumonia or blood stream infection</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pneumonia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood stream infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With ICU Admission</title>
        <description>new admission to the intensive care unit</description>
        <time_frame>within 2 days post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fresh Frozen Plasma Transfusion</title>
            <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
          </group>
          <group group_id="O2">
            <title>No Transfusion</title>
            <description>No transfusions prior to the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With ICU Admission</title>
          <description>new admission to the intensive care unit</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>In-hospital (for up to 7 days)</time_frame>
      <desc>Adverse events were captured via daily medical record review</desc>
      <group_list>
        <group group_id="E1">
          <title>Fresh Frozen Plasma Transfusion</title>
          <description>Pre-procedure fresh frozen plasma transfusion (15 cc per Kg, range 10-20 cc/Kg, to a maximum of 5 units)&#xD;
Fresh frozen plasma transfusion: Pre-procedure fresh frozen plasma transfusion (15 cc per Kg to a maximum of 5 units)</description>
        </group>
        <group group_id="E2">
          <title>No Transfusion</title>
          <description>No transfusions prior to the procedure</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Congestive Heart Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Liver Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Blood Stream Infrection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Septic Shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jeffrey L Carson, MD</name_or_title>
      <organization>Rutgers, The State University of New Jersey</organization>
      <phone>732-235-7122</phone>
      <email>Jeffrey.Carson@Rutgers.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

